Aisling Capital as of June 30, 2018
Portfolio Holdings for Aisling Capital
Aisling Capital holds 9 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 78.3 | $597M | 3.4M | 173.48 | |
| Aimmune Therapeutics | 7.9 | $60M | 2.2M | 26.89 | |
| Viewray (VRAYQ) | 6.8 | $52M | 7.5M | 6.92 | |
| Transenterix | 3.7 | $28M | 6.4M | 4.36 | |
| Adma Biologics (ADMA) | 2.1 | $16M | 3.6M | 4.51 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.7 | $5.3M | 1.0M | 5.20 | |
| Chimerix (CMRX) | 0.3 | $2.3M | 473k | 4.76 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $1.1M | 2.5M | 0.44 | |
| Pernix Therapeutics Holdings | 0.1 | $510k | 210k | 2.43 |
